| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMP | Common Stock | Options Exercise | $29.4K | +723 | +5.77% | $40.60 | 13.2K | 08 Nov 2022 | Direct | |
| transaction | TMP | Common Stock | Tax liability | -$42.3K | -521 | -3.93% | $81.23 | 12.7K | 08 Nov 2022 | Direct | F1 |
| holding | TMP | Common Stock | 1.8K | 08 Nov 2022 | by 401(K) ESOP | ||||||
| holding | TMP | Common Stock | 118 | 08 Nov 2022 | by 401(K) ISOP |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMP | Stock Appreciation Rights (SAR) | Options Exercise | $0 | -723 | -100% | $0.00* | 0 | 08 Nov 2022 | Common Stock | 723 | $40.60 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Shares withheld for Option cost and taxes |
| F2 | Stock Appreciation Rights (SARs) were granted pursuant to the Tompkins Financial Corporation 2009 Equity Plan. SARs have a seven year vesting schedule with 0% vesting in year one, 17% vesting in years two through six, and 15% vesting in year seven. When exercised, the SARs will be settled in Common Stock of the Company. The grant will expire ten years from the date of the grant. |